Artificial Intelligence in Drug Development: From Molecular Design to Clinical Pharmacometrics

Abstract

The aim was to demonstrate the potential of using artificial intelligence (AI) in pharmacology and the development of new drugs. This study reviews the key technological drivers shaping the market for generative design and AI applications in medicine, the dynamics of the global AI drug discovery market, the activities of leading players and startups, and the regulatory and legal aspects governing the industry. Particular focus is placed on the Russian market, including its maturity, growth barriers, and AI adoption case studies from 2022 to 2025.